The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABBVIE INC | COM | 00287Y109 | 174,016 | 1,613,200 | SH | SOLE | 1,613,200 | 0 | 0 | ||
AC IMMUNE SA | SHS | H00263105 | 11,673 | 1,739,600 | SH | SOLE | 1,739,600 | 0 | 0 | ||
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 9,136 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
ACCELERON PHARMA INC | COM | 00434H108 | 6,024 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
ACCELERON PHARMA INC | COM | 00434H108 | 211,356 | 1,228,100 | SH | Call | SOLE | 1,228,100 | 0 | 0 | |
ADICET BIO INC | COM | 007002108 | 18,970 | 2,419,600 | SH | SOLE | 2,419,600 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 80,622 | 427,000 | SH | SOLE | 427,000 | 0 | 0 | ||
ALPHATEC HLDGS INC | COM NEW | 02081G201 | 33,961 | 2,786,000 | SH | SOLE | 2,786,000 | 0 | 0 | ||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 20,614 | 1,932,000 | SH | SOLE | 1,932,000 | 0 | 0 | ||
ALTIMMUNE INC | COM NEW | 02155H200 | 24,519 | 2,167,900 | SH | SOLE | 2,167,900 | 0 | 0 | ||
ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 67,827 | 1,139,000 | SH | SOLE | 1,139,000 | 0 | 0 | ||
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 42,059 | 673,700 | SH | SOLE | 673,700 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 183,648 | 2,234,700 | SH | SOLE | 2,234,700 | 0 | 0 | ||
ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 5,025 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 84,805 | 1,412,000 | SH | SOLE | 1,412,000 | 0 | 0 | ||
ATAI LIFE SCIENCES NV | SHS | N0731H103 | 3,235 | 218,730 | SH | SOLE | 218,730 | 0 | 0 | ||
AVANTOR INC | COM | 05352A100 | 132,831 | 3,247,700 | SH | SOLE | 3,247,700 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 40,516 | 1,645,000 | SH | SOLE | 1,645,000 | 0 | 0 | ||
BAXTER INTL INC | COM | 071813109 | 69,331 | 862,000 | SH | SOLE | 862,000 | 0 | 0 | ||
BCLS ACQUISITION CORP | COM CL A | G0904B105 | 4,980 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 30,344 | 4,942,000 | SH | SOLE | 4,942,000 | 0 | 0 | ||
BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 129,770 | 934,200 | SH | SOLE | 934,200 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 85,538 | 832,000 | SH | SOLE | 832,000 | 0 | 0 | ||
CAREMAX INC | COM CL A | 14171W103 | 7,993 | 827,402 | SH | SOLE | 827,402 | 0 | 0 | ||
CARIBOU BIOSCIENCES INC | COM | 142038108 | 59,056 | 2,474,067 | SH | SOLE | 2,474,067 | 0 | 0 | ||
CATALENT INC | COM | 148806102 | 52,962 | 398,000 | SH | SOLE | 398,000 | 0 | 0 | ||
CENTURY THERAPEUTICS INC | COM | 15673T100 | 18,600 | 739,269 | SH | SOLE | 739,269 | 0 | 0 | ||
COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | 34,709 | 1,162,000 | SH | SOLE | 1,162,000 | 0 | 0 | ||
CYTEIR THERAPEUTICS INC | COM | 23284P103 | 29,544 | 1,683,441 | SH | SOLE | 1,683,441 | 0 | 0 | ||
DYNAMICS SPECIAL PURPOSE COR | CLASS A COM | 268010105 | 4,970 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
ENGAGESMART INC | COMMON STOCK | 29283F103 | 9,367 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
ESSA PHARMA INC | COM NEW | 29668H708 | 19,600 | 2,450,000 | SH | SOLE | 2,450,000 | 0 | 0 | ||
EXACT SCIENCES CORP | COM | 30063P105 | 35,221 | 369,000 | SH | SOLE | 369,000 | 0 | 0 | ||
FIELD TRIP HEALTH LTD | COM | 31656R102 | 16,437 | 3,581,000 | SH | SOLE | 3,581,000 | 0 | 0 | ||
GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | 12,354 | 560,000 | SH | SOLE | 560,000 | 0 | 0 | ||
GRAPHITE BIO INC | COM | 38870X104 | 12,276 | 748,995 | SH | SOLE | 748,995 | 0 | 0 | ||
GRITSTONE BIO INC | COM | 39868T105 | 48,145 | 4,457,831 | SH | SOLE | 4,457,831 | 0 | 0 | ||
HARPOON THERAPEUTICS INC | COM | 41358P106 | 9,406 | 1,190,600 | SH | SOLE | 1,190,600 | 0 | 0 | ||
HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 3,956 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
HEALTHCOR CATALIO ACQU CORP | CL A SHS | G44125105 | 4,950 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
HELIX ACQUISITION CORP | COM CL A | G4444C102 | 3,940 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
HOLOGIC INC | COM | 436440101 | 69,780 | 945,400 | SH | SOLE | 945,400 | 0 | 0 | ||
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 90,480 | 826,000 | SH | SOLE | 826,000 | 0 | 0 | ||
I MAB | SPONSORED ADS | 44975P103 | 32,910 | 454,000 | SH | SOLE | 454,000 | 0 | 0 | ||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 62,119 | 2,437,000 | SH | SOLE | 2,437,000 | 0 | 0 | ||
IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 40,614 | 1,095,600 | SH | SOLE | 1,095,600 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 35,582 | 1,292,000 | SH | SOLE | 1,292,000 | 0 | 0 | ||
INSTIL BIO INC | COM | 45783C101 | 7,296 | 408,140 | SH | SOLE | 408,140 | 0 | 0 | ||
INTELLIA THERAPEUTICS INC | COM | 45826J105 | 33,672 | 251,000 | SH | SOLE | 251,000 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 36,058 | 1,462,200 | SH | SOLE | 1,462,200 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 66,584 | 4,100,000 | SH | SOLE | 4,100,000 | 0 | 0 | ||
KEROS THERAPEUTICS INC | COM | 492327101 | 5,740 | 145,100 | SH | SOLE | 145,100 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 2,246 | 260,000 | SH | SOLE | 260,000 | 0 | 0 | ||
KYMERA THERAPEUTICS INC | COM | 501575104 | 30,222 | 514,500 | SH | SOLE | 514,500 | 0 | 0 | ||
LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | 45,201 | 894,000 | SH | SOLE | 894,000 | 0 | 0 | ||
LIFESCI ACQUISITION II CORP | COM | 53229E103 | 3,920 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
LIFESTANCE HEALTH GROUP INC | COM | 53228F101 | 14,500 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
LILLY ELI & CO | COM | 532457108 | 76,247 | 330,000 | SH | SOLE | 330,000 | 0 | 0 | ||
MEDICUS SCIENCES ACQUISITION | CL A SHS | G5960S108 | 5,070 | 520,000 | SH | SOLE | 520,000 | 0 | 0 | ||
MEDICUS SCIENCES ACQUISITION | *W EXP 02/12/202 | G5960S124 | 41 | 57,770 | SH | SOLE | 57,770 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 187,949 | 1,062,400 | SH | SOLE | 1,062,400 | 0 | 0 | ||
MONTE ROSA THERAPEUTICS INC | COM | 61225M102 | 6,684 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
NATERA INC | COM | 632307104 | 71,177 | 638,700 | SH | SOLE | 638,700 | 0 | 0 | ||
NAUTILUS BIOTECHNOLOGY INC | COM | 63909J108 | 3,684 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 81,418 | 848,900 | SH | SOLE | 848,900 | 0 | 0 | ||
NUVATION BIO INC | COM CL A | 67080N101 | 72,199 | 7,263,488 | SH | SOLE | 7,263,488 | 0 | 0 | ||
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 253 | 99,999 | SH | SOLE | 99,999 | 0 | 0 | ||
ONCOSEC MED INC | COM | 68234L306 | 6,273 | 2,945,000 | SH | SOLE | 2,945,000 | 0 | 0 | ||
ORCHARD THERAPEUTICS PLC | ADS | 68570P101 | 8,825 | 3,836,798 | SH | SOLE | 3,836,798 | 0 | 0 | ||
ORTHO CLINICAL DIAGNOSTICS H | ORD SHS | G6829J107 | 44,315 | 2,398,000 | SH | SOLE | 2,398,000 | 0 | 0 | ||
PANACEA ACQUISITION CORP II | CL A SHS | G6882C106 | 4,885 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
PFIZER INC | COM | 717081103 | 44,163 | 1,026,800 | SH | SOLE | 1,026,800 | 0 | 0 | ||
PHASEBIO PHARMACEUTICALS INC | COM | 717224109 | 13,700 | 4,405,000 | SH | SOLE | 4,405,000 | 0 | 0 | ||
REGENERON PHARMACEUTICALS | COM | 75886F107 | 92,169 | 152,300 | SH | SOLE | 152,300 | 0 | 0 | ||
SANA BIOTECHNOLOGY INC | COM | 799566104 | 17,445 | 774,644 | SH | SOLE | 774,644 | 0 | 0 | ||
SCYNEXIS INC | COM NEW | 811292200 | 10,918 | 2,060,000 | SH | SOLE | 2,060,000 | 0 | 0 | ||
SEAGEN INC | COM | 81181C104 | 91,183 | 537,000 | SH | SOLE | 537,000 | 0 | 0 | ||
SEASPINE HLDGS CORP | COM | 81255T108 | 30,563 | 1,943,000 | SH | SOLE | 1,943,000 | 0 | 0 | ||
SEMA4 HOLDINGS CORP | COM CL A | 81663L101 | 12,599 | 1,660,000 | SH | SOLE | 1,660,000 | 0 | 0 | ||
SENTINELONE INC | CL A | 81730H109 | 10,714 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SHATTUCK LABS INC | COM | 82024L103 | 41,270 | 2,025,000 | SH | SOLE | 2,025,000 | 0 | 0 | ||
SI-BONE INC | COM | 825704109 | 17,804 | 831,200 | SH | SOLE | 831,200 | 0 | 0 | ||
SIGHT SCIENCES INC | COM | 82657M105 | 3,296 | 145,189 | SH | SOLE | 145,189 | 0 | 0 | ||
SOCIAL CAP SUVRETTA HLD CRPI | CLASS A ORD SHS | G8253W109 | 1,960 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SOCIAL CAP SUVRETTA HLDS CP | CLASS A ORD SHS | G8253Y105 | 1,962 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SOCIAL CAP SUVRETTA HLDS CRP | CLASS A ORD SHS | G8253T106 | 1,990 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SOCIAL CAP SUVRETTA HLDS CRP | CLASS A ORD SHS | G8253U103 | 1,976 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SOMALOGIC INC | CLASS A COM | 83444K105 | 4,089 | 330,000 | SH | SOLE | 330,000 | 0 | 0 | ||
SOMALOGIC INC | *W EXP 03/01/202 | 83444K113 | 228 | 65,999 | SH | SOLE | 65,999 | 0 | 0 | ||
SOTERA HEALTH CO | COM | 83601L102 | 62,185 | 2,378,000 | SH | SOLE | 2,378,000 | 0 | 0 | ||
SPDR SER TR | S&P BIOTECH | 78464A870 | 379,770 | 3,021,000 | SH | Call | SOLE | 3,021,000 | 0 | 0 | |
STEVANATO GROUP S P A | ORD SHS | T9224W109 | 64,335 | 2,541,893 | SH | SOLE | 2,541,893 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 92,175 | 4,823,400 | SH | SOLE | 4,823,400 | 0 | 0 | ||
TALARIS THERAPEUTICS INC | COM | 87410C104 | 6,170 | 455,000 | SH | SOLE | 455,000 | 0 | 0 | ||
TANGO THERAPEUTICS INC | COM | 87583X109 | 3,879 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
UIPATH INC | CL A | 90364P105 | 16,783 | 319,000 | SH | SOLE | 319,000 | 0 | 0 | ||
ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 41,036 | 455,000 | SH | SOLE | 455,000 | 0 | 0 | ||
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 64,788 | 351,000 | SH | SOLE | 351,000 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 168,040 | 926,400 | SH | SOLE | 926,400 | 0 | 0 | ||
VIR BIOTECHNOLOGY INC | COM | 92764N102 | 22,413 | 515,000 | SH | SOLE | 515,000 | 0 | 0 | ||
WEREWOLF THERAPEUTICS INC | COM | 95075A107 | 10,727 | 625,120 | SH | SOLE | 625,120 | 0 | 0 | ||
ZAI LAB LTD | ADR | 98887Q104 | 3,752 | 35,600 | SH | SOLE | 35,600 | 0 | 0 | ||
ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 166,187 | 2,493,800 | SH | SOLE | 2,493,800 | 0 | 0 | ||
ZETA GLOBAL HOLDINGS CORP | CL A | 98956A105 | 7,618 | 1,300,000 | SH | SOLE | 1,300,000 | 0 | 0 | ||
ZIOPHARM ONCOLOGY INC | COM | 98973P101 | 5,460 | 3,000,000 | SH | SOLE | 3,000,000 | 0 | 0 |